Tissue resistance to insulin action results from abnormalities affecting the insulin signalling cascade. This intricate molecular pathway, controlled by positive and negative regulators, affects most major areas of metabolism (Fig. 1). Our growing comprehension of the complexity of these biochemical mechanisms makes it difficult to ascertain exactly what is happening in the insulin-resistant patient.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.